| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Haider Ghazanfar, Nismat Javed, Abeer Qasim, Franklin Sosa, Faryal Altaf, Shazia Khan, Jaydeep Mahasamudram, Abhilasha Jyala, Sameer Datta Kandhi, Dongmin Shin, Nikhitha Mantri, Haozhe Sun, Siddarth Hanumanthu, Harish Patel, Jasbir Makker, Bhavna Balar, Anil Dev and Sridhar Chilimuri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sameer Datta Kandhi, MD, N/A, N/A, Division of Gastroenterology, Department of Internal Medicine, BronxCare Health System, Icahn School of Medicine at Mount Sinai, 1650 Selwyn Avenue Suite 10 C, Bronx, NY 10457, United States. skandhi@bronxcare.org |
| Key Words |
Glucagon-like peptide-1 agonists; Gastroparesis; Endoscopic procedures; Residual food; Complications |
| Core Tip |
This retrospective study assessed the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on gastric residual contents during endoscopy. Patients on a clear liquid diet had significantly lower residual food rates (1.5%) compared to those on a regular diet (10%, P = 0.03). Among patients with digestive symptoms, 13% had residual food, all from the regular diet group (P = 0.130). No complications occurred during or after the procedures. The study suggests that a 24-hour liquid diet is safe for endoscopic procedures. However, further research is needed to understand residual food risks in patients with upper gastrointestinal symptoms and to evaluate risks based on diabetes duration, gastroparesis presence, and GLP-1 RA dosing. |
| Publish Date |
2024-07-09 14:00 |
| Citation |
<p>Ghazanfar H, Javed N, Qasim A, Sosa F, Altaf F, Khan S, Mahasamudram J, Jyala A, Kandhi SD, Shin D, Mantri N, Sun H, Hanumanthu S, Patel H, Makker J, Balar B, Dev A, Chilimuri S. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study. <i>World J Gastroenterol</i> 2024; 30(26): 3221-3228</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i26/3221.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i26.3221 |
